Fenofibrate Tablets and Gengraf Oral Solution
Determining the interaction of Fenofibrate Tablets and Gengraf Oral Solution and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using cycloSPORINE together with fenofibrate can cause damage to the kidneys. Symptoms of kidney damage include swelling, weight gain, feeling short of breath, drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting, pain in your lower back, and urinating more or less than usual or not at all. If you take both medications together, tell your doctor if you have any of these symptoms. You may need a dose adjustment or special tests to safely use these medications together. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: The concomitant use of cyclosporine and fibric acid derivatives may increase the risk of nephrotoxicity. Fibrates are primarily eliminated by the kidneys and increases in serum creatinine and/or cyclosporine levels may occur.
MANAGEMENT: The manufacturer recommends caution during concomitant administration. Renal function should be closely monitored and the lowest effective dose should be used.
- Canadian Pharmacists Association "e-CPS. Available from: URL: http://www.pharmacists.ca/function/Subscriptions/ecps.cfm?link=eCPS_quikLink."
- Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp." ([2006]):
- "Product Information. Trilipix (fenofibric acid)." Abbott Pharmaceutical, Abbott Park, IL.
- "Product Information. Tricor (fenofibrate)." Abbott Pharmaceutical, Abbott Park, IL.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Adkins JC, Faulds D "Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia." Drugs 54 (1997): 615-33
- deLorgeril M, Boissonnat P, Bizollon CA, et al "Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation: lack of interaction with the lipid-lowering agent, fenofibrate." Eur J Clin Pharmacol 43 (1992): 161-5
Generic Name: fenofibrate
Brand name: Antara, Fenoglide, Lipofen, Tricor, Triglide, Lipidil Micro, Dom-Fenofibrate, Lipidil Supra, Lofibra, Lipidil EZ
Synonyms: Fenofibrate, Fenofibrate and Derivatives
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Gengraf (Capsules, Modified), Gengraf
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fenofibrate Tablets-Genicin
- Fenofibrate Tablets-Genicin Vita-Q
- Fenofibrate Tablets-Genotropin
- Fenofibrate Tablets-Genotropin Miniquick
- Fenofibrate Tablets-Genpril
- Fenofibrate Tablets-Gentamicin
- Gengraf Oral Solution-Fenofibric acid
- Gengraf Oral Solution-Fenofibric Acid Delayed Release Capsules
- Gengraf Oral Solution-Fenofibric Acid/Fenofibrate
- Gengraf Oral Solution-Fenoglide
- Gengraf Oral Solution-Fenoldopam
- Gengraf Oral Solution-Fenoldopam Intravenous